{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 123, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:44:40Z", "timestamp": 1574178280010}, "reference-count": 11, "publisher": "Springer Science and Business Media LLC", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Pharmacokinetics"], "published-print": {"date-parts": [[2003]]}, "DOI": "10.2165/00003088-200342040-00004", "type": "journal-article", "created": {"date-parts": [[2006, 1, 19]], "date-time": "2006-01-19T12:19:04Z", "timestamp": 1137673144000}, "page": "361-372", "source": "Crossref", "is-referenced-by-count": 92, "title": ["Pharmacokinetics of Selective Estrogen Receptor Modulators"], "prefix": "10.1007", "volume": "42", "author": [{"given": "Karla C.", "family": "Morello", "sequence": "first", "affiliation": []}, {"given": "Gregory T.", "family": "Wurz", "sequence": "additional", "affiliation": []}, {"given": "Michael W.", "family": "DeGregorio", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "5", "key": "R19-4", "doi-asserted-by": "crossref", "first-page": "388", "DOI": "10.1634/theoncologist.5-5-388", "volume": "5", "author": "Muchmore", "year": "2000", "journal-title": "Oncologist"}, {"issue": "4", "key": "R20-4", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1007/s001980050236", "volume": "10", "author": "Meunier", "year": "1999", "journal-title": "Osteoporos Int"}, {"key": "R25-4", "author": "Viopio", "volume": "43", "first-page": "207", "year": "2002", "journal-title": "Maturitas", "DOI": "10.1016/S0378-5122(02)00206-2", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "R31-4", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1007/BF00435413", "volume": "5", "author": "Wilkinson", "year": "1980", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "4", "key": "R33-4", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1007/BF00684880", "volume": "25", "author": "Wiebe", "year": "1990", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "3", "key": "R45-4", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1111/j.1600-0773.1982.tb00958.x", "volume": "50", "author": "Wilking", "year": "1982", "journal-title": "Acta Pharmacol Toxicol"}, {"issue": "2", "key": "R51-4", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1007/s002800050645", "volume": "40", "author": "Sotaniemi", "year": "1997", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "1", "key": "R58-4", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1007/BF00689269", "volume": "27", "author": "Kangas", "year": "1990", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "3", "key": "R59-4", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1007/BF00686307", "volume": "30", "author": "Bishop", "year": "1992", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "2", "key": "R61-4", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1016/0163-7258(84)90043-3", "volume": "25", "author": "Furr", "year": "1984", "journal-title": "Pharmacol Ther"}, {"issue": "3", "key": "R66-4", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1007/BF00267955", "volume": "23", "author": "DeGregorio", "year": "1989", "journal-title": "Cancer Chemother Pharmacol"}], "container-title": ["Clinical Pharmacokinetics"], "language": "en", "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T12:58:51Z", "timestamp": 1553173131000}, "score": 50.281845, "subtitle": [""], "issued": {"date-parts": [[2003]]}, "references-count": 11, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.2165/00003088-200342040-00004", "relation": {"cites": []}, "ISSN": ["0312-5963"], "issn-type": [{"value": "0312-5963", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:19:35Z", "timestamp": 1574432375414}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2011, 12, 1]], "date-time": "2011-12-01T00:00:00Z", "timestamp": 1322697600000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["IJGM"], "DOI": "10.2147/ijgm.s26889", "type": "journal-article", "created": {"date-parts": [[2011, 12, 12]], "date-time": "2011-12-12T02:14:48Z", "timestamp": 1323656088000}, "page": "827", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus"], "prefix": "10.2147", "author": [{"given": "Candis", "family": "Morello", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2011, 12]]}, "container-title": ["International Journal of General Medicine"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=11593", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:21:10Z", "timestamp": 1477866070000}, "score": 21.58139, "issued": {"date-parts": [[2011, 12]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/ijgm.s26889", "ISSN": ["1178-7074"], "issn-type": [{"value": "1178-7074", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:48:43Z", "timestamp": 1574153323025}, "reference-count": 0, "publisher": "Bioscientifica", "issue": "2", "content-domain": {"domain": ["joe.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2000, 11, 1]]}, "abstract": "<jats:p>Recent data indicate that the catechol estrogen, 2-hydroxyestrone (2-OHE(1)), has no effect on any target tissue including bone, whereas 16 alpha-hydroxyestrone (16 alpha-OHE(1)) exerts tissue-selective estrogen agonist activity. The effect of the catechol estrogen, 4-hydroxyestrone (4-OHE(1)), putatively associated with tumorigenesis, has not been studied in the skeleton. The purpose of this study was to assess the effect of 4-OHE(1) on tibia, uterine and mammary gland histology and blood cholesterol in ovariectomized (OVX'd) growing rats. Ten-week-old female Sprague-Dawley rats were injected subcutaneously with 200 microg/kg BW per day with 4-OHE(1), 17 beta-estradiol (E(2)) or vehicle for three weeks. OVX resulted in uterine atrophy, increased body weight, radial bone growth and cancellous bone turnover, and hypercholesterolemia. E(2) prevented these changes with the expected exception that the subcutaneous infusion of this high dose of estrogen did not prevent the hypercholesterolemia. 4-OHE(1) prevented the increase in blood cholesterol and the increase in body weight. 4-OHE(1) appeared to have partial estrogen activity in the uterus; uterine weight and epithelial cell height were significantly greater than the OVX rats but significantly less (twofold) than the E(2) animals. Analysis of variance indicated that 4-OHE(1) slightly decreased the periosteal mineral apposition rate (P&lt;0.05) compared with vehicle-treated rats but had no effect on double-labeled perimeter or bone formation rate. Similarly, 4-OHE(1) was a partial estrogen agonist on cancellous bone turnover. The data suggest that the catechol estrogen, 4-OHE(1), unlike 2-OHE(1), has estrogen activity. Furthermore, the profile of activity differs from that of 16 alpha-OHE(1). Our results suggest that estrogen metabolites may selectively influence estrogen-target tissues and, concomitantly, modulate estrogen-associated disease risk.</jats:p>", "DOI": "10.1677/joe.0.1670281", "type": "journal-article", "created": {"date-parts": [[2004, 12, 2]], "date-time": "2004-12-02T23:42:13Z", "timestamp": 1102030933000}, "page": "281-287", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 9, "title": ["The catechol estrogen, 4-hydroxyestrone, has tissue-specific estrogen actions"], "prefix": "10.1530", "volume": "167", "author": [{"given": "KC", "family": "Westerlind", "sequence": "first", "affiliation": []}, {"given": "KJ", "family": "Gibson", "sequence": "additional", "affiliation": []}, {"given": "GL", "family": "Evans", "sequence": "additional", "affiliation": []}, {"given": "RT", "family": "Turner", "sequence": "additional", "affiliation": []}], "member": "416", "container-title": ["Journal of Endocrinology"], "link": [{"URL": "https://joe.bioscientifica.com/view/journals/joe/167/2/281.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T14:58:45Z", "timestamp": 1556117925000}, "score": 18.55495, "issued": {"date-parts": [[2000, 11, 1]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1677/joe.0.1670281", "ISSN": ["0022-0795", "1479-6805"], "issn-type": [{"value": "0022-0795", "type": "print"}, {"value": "1479-6805", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T02:04:37Z", "timestamp": 1575511477140}, "reference-count": 26, "publisher": "Medknow", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["South Asian J Cancer"], "published-print": {"date-parts": [[2018]]}, "DOI": "10.4103/sajc.sajc_211_17", "type": "journal-article", "created": {"date-parts": [[2019, 9, 11]], "date-time": "2019-09-11T11:46:16Z", "timestamp": 1568202376000}, "page": "7", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Estrogen receptor, Progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: A retrospective study of 5436 women from a regional cancer center in South India"], "prefix": "10.4103", "volume": "7", "author": [{"given": "RekhaVijay", "family": "Kumar", "sequence": "first", "affiliation": []}, {"given": "Dipti", "family": "Panwar", "sequence": "additional", "affiliation": []}, {"given": "Usha", "family": "Amirtham", "sequence": "additional", "affiliation": []}, {"given": "ChennagiriSrinivasmurthy", "family": "Premalata", "sequence": "additional", "affiliation": []}, {"given": "Champaka", "family": "Gopal", "sequence": "additional", "affiliation": []}, {"given": "SumaMysore", "family": "Narayana", "sequence": "additional", "affiliation": []}, {"given": "GeethaVikram", "family": "Patil Okaly", "sequence": "additional", "affiliation": []}, {"given": "KC", "family": "Lakshmaiah", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Krishnamurthy", "sequence": "additional", "affiliation": []}], "member": "2581", "container-title": ["South Asian Journal of Cancer"], "language": "en", "deposited": {"date-parts": [[2019, 9, 11]], "date-time": "2019-09-11T11:46:39Z", "timestamp": 1568202399000}, "score": 18.444317, "issued": {"date-parts": [[2018]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2018]]}, "issue": "1"}, "alternative-id": ["226800"], "URL": "http://dx.doi.org/10.4103/sajc.sajc_211_17", "ISSN": ["2278-330X"], "issn-type": [{"value": "2278-330X", "type": "print"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:40:10Z", "timestamp": 1574811610122}, "reference-count": 0, "publisher": "OAE Publishing Inc.", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCMT"], "DOI": "10.20517/2394-4722.2017.29", "type": "journal-article", "created": {"date-parts": [[2017, 7, 17]], "date-time": "2017-07-17T09:52:36Z", "timestamp": 1500285156000}, "page": "127", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target"], "prefix": "10.20517", "volume": "3", "author": [{"given": "Claudia", "family": "Sorrentino", "sequence": "first", "affiliation": []}, {"given": "Silvana", "family": "Morello", "sequence": "additional", "affiliation": []}], "member": "8410", "published-online": {"date-parts": [[2017, 7, 17]]}, "container-title": ["Journal of Cancer Metastasis and Treatment"], "link": [{"URL": "http://jcmtjournal.com/article/viewFile/2158/1572", "content-type": "text/html", "content-version": "vor", "intended-application": "similarity-checking"}, {"URL": "http://jcmtjournal.com/article/viewFile/2158/1575", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 17]], "date-time": "2017-07-17T09:52:36Z", "timestamp": 1500285156000}, "score": 17.371262, "issued": {"date-parts": [[2017, 7, 17]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2017, 7, 14]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.20517/2394-4722.2017.29", "ISSN": ["2454-2857", "2394-4722"], "issn-type": [{"value": "2394-4722", "type": "print"}, {"value": "2454-2857", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 21]], "date-time": "2019-12-21T03:43:14Z", "timestamp": 1576899794743}, "reference-count": 9, "publisher": "Informa UK Limited", "issue": "3", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["OncoImmunology"], "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.4161/onci.27989", "type": "journal-article", "created": {"date-parts": [[2014, 4, 25]], "date-time": "2014-04-25T00:26:53Z", "timestamp": 1398385613000}, "page": "e27989", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells"], "prefix": "10.1080", "volume": "3", "author": [{"given": "Silvana", "family": "Morello", "sequence": "first", "affiliation": []}, {"given": "Lucio", "family": "Miele", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 2, 14]]}, "reference": [{"key": "R1", "author": "Iannone R", "volume": "15", "first-page": "1400", "year": "2013", "journal-title": "Neoplasia", "DOI": "10.1593/neo.131748", "doi-asserted-by": "crossref"}, {"key": "R2", "author": "Ryzhov S", "volume": "10", "first-page": "987", "year": "2008", "journal-title": "Neoplasia", "DOI": "10.1593/neo.08478", "doi-asserted-by": "crossref"}, {"key": "R3", "DOI": "10.4049/jimmunol.1101225", "doi-asserted-by": "publisher"}, {"key": "R4", "DOI": "10.1038/nri3175", "doi-asserted-by": "publisher"}, {"key": "R5", "DOI": "10.1038/nri2506", "doi-asserted-by": "publisher"}, {"key": "R6", "DOI": "10.1038/nrc2444", "doi-asserted-by": "publisher"}, {"key": "R7", "DOI": "10.1172/JCI35213", "doi-asserted-by": "publisher"}, {"key": "R8", "DOI": "10.1002/ijc.22084", "doi-asserted-by": "publisher"}, {"key": "R9", "DOI": "10.1158/0008-5472.CAN-11-2449", "doi-asserted-by": "publisher"}], "container-title": ["OncoImmunology"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.4161/onci.27989", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T12:09:15Z", "timestamp": 1498133355000}, "score": 17.371262, "issued": {"date-parts": [[2014, 2, 14]]}, "references-count": 9, "journal-issue": {"published-online": {"date-parts": [[2014, 3, 27]]}, "published-print": {"date-parts": [[2014, 3]]}, "issue": "3"}, "alternative-id": ["10.4161/onci.27989"], "URL": "http://dx.doi.org/10.4161/onci.27989", "relation": {"cites": []}, "ISSN": ["2162-402X"], "issn-type": [{"value": "2162-402X", "type": "electronic"}], "subject": ["Immunology", "Immunology and Allergy", "Oncology"], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=koni20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=koni20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:04:39Z", "timestamp": 1574813079435}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2009, 8, 1]], "date-time": "2009-08-01T00:00:00Z", "timestamp": 1249084800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JRLCR"], "DOI": "10.2147/jrlcr.s4710", "type": "journal-article", "created": {"date-parts": [[2016, 6, 30]], "date-time": "2016-06-30T00:24:14Z", "timestamp": 1467246254000}, "page": "11-17", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities"], "prefix": "10.2147", "volume": "Volume 2", "author": [{"given": "Silvana", "family": "Morello", "sequence": "first", "affiliation": []}, {"given": "Rosalinda", "family": "Sorrentino", "sequence": "additional", "affiliation": []}, {"given": "Aldo", "family": "Pinto", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 8]]}, "container-title": ["Journal of Receptor, Ligand and Channel Research"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=5128", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:03:06Z", "timestamp": 1477864986000}, "score": 17.358778, "issued": {"date-parts": [[2009, 8]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/jrlcr.s4710", "ISSN": ["1178-699X"], "issn-type": [{"value": "1178-699X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T19:25:28Z", "timestamp": 1574796328109}, "reference-count": 0, "publisher": "OMICS Publishing Group", "issue": "01", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Integr Oncol"], "DOI": "10.4172/2329-6771.1000159", "type": "journal-article", "created": {"date-parts": [[2016, 5, 13]], "date-time": "2016-05-13T11:07:43Z", "timestamp": 1463137663000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Analysis of Clinico-Pathological Characteristics of Indian Breast Cancers Shows Conservation of Specific Features in the Hormone Receptor Sub-Types"], "prefix": "10.4172", "volume": "05", "author": [{"given": "Geetashree", "family": "Mukherjee", "sequence": "first", "affiliation": []}, {"given": "KC", "family": "Lakshmaiah", "sequence": "additional", "affiliation": []}], "member": "2674", "published-online": {"date-parts": [[2016]]}, "container-title": ["Journal of Integrative Oncology"], "deposited": {"date-parts": [[2016, 5, 13]], "date-time": "2016-05-13T11:07:45Z", "timestamp": 1463137665000}, "score": 17.215776, "issued": {"date-parts": [[2016]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016]]}, "issue": "01"}, "URL": "http://dx.doi.org/10.4172/2329-6771.1000159", "ISSN": ["2329-6771"], "issn-type": [{"value": "2329-6771", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T15:55:55Z", "timestamp": 1575388555561}, "reference-count": 0, "publisher": "Acoustical Society of America (ASA)", "issue": "5", "content-domain": {"domain": ["asa.scitation.org"], "crossmark-restriction": true}, "short-container-title": ["The Journal of the Acoustical Society of America"], "published-print": {"date-parts": [[2013, 11]]}, "DOI": "10.1121/1.4831545", "type": "journal-article", "created": {"date-parts": [[2013, 11, 1]], "date-time": "2013-11-01T23:32:03Z", "timestamp": 1383348723000}, "page": "4230-4230", "update-policy": "http://dx.doi.org/10.1063/aip-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Selective and divided attention: Spatial orienting in a semantic classification task"], "prefix": "10.1121", "volume": "134", "author": [{"given": "Daniel", "family": "McCloy", "sequence": "first", "affiliation": []}, {"given": "Adrian KC", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "231", "container-title": ["The Journal of the Acoustical Society of America"], "language": "en", "deposited": {"date-parts": [[2016, 12, 27]], "date-time": "2016-12-27T12:51:40Z", "timestamp": 1482843100000}, "score": 16.82537, "issued": {"date-parts": [[2013, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 11]]}, "issue": "5"}, "alternative-id": ["10.1121/1.4831545"], "URL": "http://dx.doi.org/10.1121/1.4831545", "ISSN": ["0001-4966"], "issn-type": [{"value": "0001-4966", "type": "print"}], "subject": ["Acoustics and Ultrasonics", "Arts and Humanities (miscellaneous)"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T16:35:47Z", "timestamp": 1575477347267}, "reference-count": 0, "publisher": "Acoustical Society of America (ASA)", "issue": "4", "content-domain": {"domain": ["asa.scitation.org"], "crossmark-restriction": true}, "short-container-title": ["The Journal of the Acoustical Society of America"], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.1121/1.4877473", "type": "journal-article", "created": {"date-parts": [[2014, 5, 21]], "date-time": "2014-05-21T00:35:08Z", "timestamp": 1400632508000}, "page": "2280-2280", "update-policy": "http://dx.doi.org/10.1063/aip-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effects of cognitive load on selective and divided auditory spatial attention"], "prefix": "10.1121", "volume": "135", "author": [{"given": "Daniel", "family": "McCloy", "sequence": "first", "affiliation": []}, {"given": "Adrian KC", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "231", "container-title": ["The Journal of the Acoustical Society of America"], "language": "en", "deposited": {"date-parts": [[2016, 12, 27]], "date-time": "2016-12-27T01:55:11Z", "timestamp": 1482803711000}, "score": 16.82537, "issued": {"date-parts": [[2014, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 4]]}, "issue": "4"}, "alternative-id": ["10.1121/1.4877473"], "URL": "http://dx.doi.org/10.1121/1.4877473", "ISSN": ["0001-4966"], "issn-type": [{"value": "0001-4966", "type": "print"}], "subject": ["Acoustics and Ultrasonics", "Arts and Humanities (miscellaneous)"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T12:54:40Z", "timestamp": 1574427280094}, "reference-count": 0, "publisher": "African Journals Online (AJOL)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4314/tjmr.v12i1.30483", "type": "journal-article", "created": {"date-parts": [[2011, 11, 30]], "date-time": "2011-11-30T09:11:13Z", "timestamp": 1322644273000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Pharmacokinetics Of Artemether-Lumefantrine Combination Therapy In Malaria Chemotherapy"], "prefix": "10.4314", "volume": "12", "author": [{"given": "JO", "family": "Nnadozie", "sequence": "first", "affiliation": []}, {"given": "PC", "family": "Unekwe", "sequence": "additional", "affiliation": []}, {"given": "KC", "family": "Chilaka", "sequence": "additional", "affiliation": []}, {"given": "PO", "family": "Okafor", "sequence": "additional", "affiliation": []}], "member": "2895", "published-online": {"date-parts": [[2009, 2, 18]]}, "container-title": ["Tropical Journal of Medical Research"], "deposited": {"date-parts": [[2011, 11, 30]], "date-time": "2011-11-30T09:11:34Z", "timestamp": 1322644294000}, "score": 16.602718, "issued": {"date-parts": [[2009, 2, 18]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 2, 18]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.4314/tjmr.v12i1.30483", "ISSN": ["1119-0388"], "issn-type": [{"value": "1119-0388", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:04:45Z", "timestamp": 1574888685483}, "reference-count": 48, "publisher": "SAGE Publications", "issue": "2", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[1989, 4, 1]], "date-time": "1989-04-01T00:00:00Z", "timestamp": 607392000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The International Journal of Biological Markers"], "published-print": {"date-parts": [[1989, 4]]}, "DOI": "10.1177/172460088900400206", "type": "journal-article", "created": {"date-parts": [[2018, 10, 16]], "date-time": "2018-10-16T08:41:07Z", "timestamp": 1539679267000}, "page": "95-102", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Correlation of an Estrogen Receptor-related Phosphoprotein with Histopathological Features in Breast Cancer"], "prefix": "10.1177", "volume": "4", "author": [{"given": "R.M.", "family": "Tomasino", "sequence": "first", "affiliation": [{"name": "Chair of Anatomy and Pathological Histology - \u201cR\u201d University of Palermo - Palermo - Italy"}]}, {"given": "E.", "family": "Daniele", "sequence": "additional", "affiliation": [{"name": "Chair of Anatomy and Pathological Histology - \u201cR\u201d University of Palermo - Palermo - Italy"}]}, {"given": "R.", "family": "Nuara", "sequence": "additional", "affiliation": [{"name": "Chair of Anatomy and Pathological Histology - \u201cR\u201d University of Palermo - Palermo - Italy"}]}, {"given": "V.", "family": "Morello", "sequence": "additional", "affiliation": [{"name": "Chair of Anatomy and Pathological Histology - \u201cR\u201d University of Palermo - Palermo - Italy"}]}, {"given": "M.", "family": "Salvato", "sequence": "additional", "affiliation": [{"name": "Chair of Anatomy and Pathological Histology - \u201cR\u201d University of Palermo - Palermo - Italy"}]}, {"given": "A.M.", "family": "Florena", "sequence": "additional", "affiliation": [{"name": "Chair of Anatomy and Pathological Histology - \u201cR\u201d University of Palermo - Palermo - Italy"}]}], "member": "179", "published-online": {"date-parts": [[2018, 10, 16]]}, "reference": [{"key": "bibr1-172460088900400206", "author": "Fisher E.R.", "volume": "36", "first-page": "1", "year": "1975", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(197507)36:1<1::AID-CNCR2820360102>3.0.CO;2-4", "doi-asserted-by": "crossref"}, {"key": "bibr2-172460088900400206", "author": "Bloom H.J.G.", "volume": "9", "first-page": "359", "year": "1957", "journal-title": "Br J Cancer", "DOI": "10.1038/bjc.1957.43", "doi-asserted-by": "crossref"}, {"key": "bibr3-172460088900400206", "author": "Coffer A.I.", "volume": "45", "first-page": "3686", "year": "1985", "journal-title": "Cancer Res"}, {"key": "bibr4-172460088900400206", "author": "King R.J.B.", "volume": "45", "first-page": "5728", "year": "1985", "journal-title": "Cancer Res"}, {"key": "bibr5-172460088900400206", "author": "Sternberger L.A.", "year": "1979", "volume-title": "Immunocytochemistry."}, {"key": "bibr6-172460088900400206", "author": "Horwitz K.B.", "volume": "89", "first-page": "726", "year": "1975", "journal-title": "Science", "DOI": "10.1126/science.168640", "doi-asserted-by": "crossref"}, {"key": "bibr7-172460088900400206", "author": "Kiang D.T.", "volume": "40", "first-page": "1571", "year": "1977", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(197710)40:4<1571::AID-CNCR2820400429>3.0.CO;2-5", "doi-asserted-by": "crossref"}, {"key": "bibr8-172460088900400206", "author": "Lee S.H.", "volume": "44", "first-page": "712", "year": "1979", "journal-title": "Cancer"}, {"key": "bibr9-172460088900400206", "author": "Poulsen S.H.", "volume": "48", "first-page": "1791", "year": "1981", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19811015)48:8<1791::AID-CNCR2820480816>3.0.CO;2-Y", "doi-asserted-by": "crossref"}, {"key": "bibr10-172460088900400206", "author": "Taylor C.R.", "volume": "47", "first-page": "2634", "year": "1981", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19810601)47:11<2634::AID-CNCR2820471119>3.0.CO;2-H", "doi-asserted-by": "crossref"}, {"key": "bibr11-172460088900400206", "author": "Davis B.W.", "volume": "20", "first-page": "373", "year": "1984", "journal-title": "Eur J Cancer", "DOI": "10.1016/0277-5379(84)90084-1", "doi-asserted-by": "crossref"}, {"key": "bibr12-172460088900400206", "author": "Crawford D.", "volume": "44", "first-page": "2348", "year": "1984", "journal-title": "Cancer Res"}, {"key": "bibr13-172460088900400206", "author": "Geyer H.", "volume": "110", "first-page": "141", "year": "1985", "journal-title": "J Cancer Res Clin Oncol", "DOI": "10.1007/BF00402728", "doi-asserted-by": "crossref"}, {"key": "bibr14-172460088900400206", "author": "King R.J.B.", "volume": "45", "first-page": "293", "year": "1985", "journal-title": "Cancers Res"}, {"key": "bibr15-172460088900400206", "DOI": "10.1177/33.2.2578501", "doi-asserted-by": "publisher"}, {"key": "bibr16-172460088900400206", "author": "Guazzi A.", "volume": "56", "first-page": "1972", "year": "1985", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19851015)56:8<1972::AID-CNCR2820560814>3.0.CO;2-P", "doi-asserted-by": "crossref"}, {"key": "bibr17-172460088900400206", "author": "Pertschuk L.P.", "volume": "5", "first-page": "137", "year": "1985", "journal-title": "Breast Cancer Res Treat", "DOI": "10.1007/BF01805987", "doi-asserted-by": "crossref"}, {"key": "bibr18-172460088900400206", "author": "Dawson P.J.", "volume": "17", "first-page": "1015", "year": "1986", "journal-title": "Hum Path", "DOI": "10.1016/S0046-8177(86)80085-5", "doi-asserted-by": "crossref"}, {"key": "bibr19-172460088900400206", "author": "Vollenweider-Zerargui L.", "volume": "23", "first-page": "75", "year": "1986", "journal-title": "Cancer"}, {"key": "bibr20-172460088900400206", "author": "Charpin C.", "first-page": "4271S", "year": "1986", "journal-title": "Cancer Res"}, {"key": "bibr21-172460088900400206", "author": "Shintaku I.P.", "volume": "87", "first-page": "161", "year": "1987", "journal-title": "Am J Clin Pathol", "DOI": "10.1093/ajcp/87.2.161", "doi-asserted-by": "crossref"}, {"key": "bibr22-172460088900400206", "author": "Kodama F.", "volume": "45", "first-page": "2720", "year": "1985", "journal-title": "Cancer Res"}, {"key": "bibr23-172460088900400206", "author": "McGuire W.L.", "volume": "4", "first-page": "2", "year": "1983", "journal-title": "Seminars Oncol"}, {"key": "bibr24-172460088900400206", "author": "Antoniades K.", "volume": "74", "first-page": "497", "year": "1979", "journal-title": "Am J Clin Pathol", "DOI": "10.1093/ajcp/71.5.497", "doi-asserted-by": "crossref"}, {"key": "bibr25-172460088900400206", "DOI": "10.1177/030089168407000510", "doi-asserted-by": "publisher"}, {"key": "bibr26-172460088900400206", "author": "Stegner H.E.", "volume": "181", "first-page": "377", "year": "1986", "journal-title": "Path Res Pract", "DOI": "10.1016/S0344-0338(86)80070-X", "doi-asserted-by": "crossref"}, {"key": "bibr27-172460088900400206", "author": "Sica V.", "first-page": "23", "year": "1979", "volume-title": "Aspetti biochimici e clinici dei tumori ormono-sensibili."}, {"key": "bibr28-172460088900400206", "author": "Jensen E.V.", "first-page": "15", "year": "1967", "volume-title": "Endogeneous factors influencing host-tumor balance."}, {"key": "bibr29-172460088900400206", "author": "Jensen E.V.", "volume": "38", "first-page": "1", "year": "1982", "journal-title": "Rec Progr Horm Res"}, {"key": "bibr30-172460088900400206", "author": "Horwitz K.B.", "volume": "253", "first-page": "2223", "year": "1978", "journal-title": "J Biol Chem"}, {"key": "bibr31-172460088900400206", "author": "Nenci I.", "volume": "32", "first-page": "139", "year": "1980", "journal-title": "Virch Arch B Celle Pathologie", "DOI": "10.1007/BF02889022", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "bibr32-172460088900400206", "first-page": "2", "volume": "10", "author": "McGuire W.L.", "year": "1983", "journal-title": "Seminars Oncol"}, {"key": "bibr33-172460088900400206", "author": "Mohammed R.H.", "volume": "58", "first-page": "1976", "year": "1986", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19860901)58:5<1076::AID-CNCR2820580516>3.0.CO;2-M", "doi-asserted-by": "crossref"}, {"key": "bibr34-172460088900400206", "author": "Rosen P.P.", "volume": "35", "first-page": "3187", "year": "1975", "journal-title": "Cancer Res"}, {"key": "bibr35-172460088900400206", "author": "Silfversward C.", "volume": "45", "first-page": "2001", "year": "1980", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19800415)45:8<2001::AID-CNCR2820450803>3.0.CO;2-3", "doi-asserted-by": "crossref"}, {"key": "bibr36-172460088900400206", "author": "Mc Carty K.S.", "volume": "46", "first-page": "2851", "year": "1980", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19801215)46:12+<2851::AID-CNCR2820461424>3.0.CO;2-K", "doi-asserted-by": "crossref"}, {"key": "bibr37-172460088900400206", "author": "Parl F.F.", "volume": "46", "first-page": "362", "year": "1980", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19800715)46:2<362::AID-CNCR2820460225>3.0.CO;2-Z", "doi-asserted-by": "crossref"}, {"key": "bibr38-172460088900400206", "author": "Fisher E.R.", "volume": "45", "first-page": "349", "year": "1980", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19800115)45:2<349::AID-CNCR2820450226>3.0.CO;2-P", "doi-asserted-by": "crossref"}, {"key": "bibr39-172460088900400206", "author": "Lesser M.L.", "volume": "48", "first-page": "299", "year": "1981", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19810715)48:2<299::AID-CNCR2820480215>3.0.CO;2-2", "doi-asserted-by": "crossref"}, {"key": "bibr40-172460088900400206", "author": "Poulsen S.H.", "volume": "397", "first-page": "103", "year": "1982", "journal-title": "Virch Arch Pathol Anat", "DOI": "10.1007/BF00430897", "doi-asserted-by": "crossref"}, {"key": "bibr41-172460088900400206", "author": "Gallager H.S.", "volume": "53", "first-page": "623", "year": "1984", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19840201)53:3+<623::AID-CNCR2820531307>3.0.CO;2-Z", "doi-asserted-by": "crossref"}, {"key": "bibr42-172460088900400206", "author": "Campobasso O.", "volume": "79", "first-page": "53", "year": "1987", "journal-title": "Pathologica"}, {"key": "bibr43-172460088900400206", "author": "Humeniuk V.", "volume": "52", "first-page": "1448", "year": "1983", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19831015)52:8<1448::AID-CNCR2820520818>3.0.CO;2-Z", "doi-asserted-by": "crossref"}, {"key": "bibr44-172460088900400206", "author": "Glaubitz L.C.", "volume": "108", "first-page": "27", "year": "1984", "journal-title": "Arch Pathol Lab Med"}, {"key": "bibr45-172460088900400206", "author": "Giri D.D.", "volume": "151", "first-page": "297", "year": "1987", "journal-title": "J Path", "DOI": "10.1002/path.1711510410", "doi-asserted-by": "crossref"}, {"key": "bibr46-172460088900400206", "author": "Rolland P.H.", "volume": "5", "first-page": "73", "year": "1980", "journal-title": "Cancer Chemother Pharmacol", "DOI": "10.1007/BF00435407", "doi-asserted-by": "crossref"}, {"key": "bibr47-172460088900400206", "author": "Horie A.", "volume": "34", "first-page": "229", "year": "1984", "journal-title": "Acta Path Jap"}, {"key": "bibr48-172460088900400206", "author": "Pucci Minafra I.", "volume": "18", "first-page": "795", "year": "1986", "journal-title": "J Submicr Cytol"}], "container-title": ["The International Journal of Biological Markers"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/172460088900400206", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/172460088900400206", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 10, 16]], "date-time": "2018-10-16T08:41:53Z", "timestamp": 1539679313000}, "score": 16.361088, "issued": {"date-parts": [[1989, 4]]}, "references-count": 48, "journal-issue": {"published-online": {"date-parts": [[2018, 10, 16]]}, "published-print": {"date-parts": [[1989, 4]]}, "issue": "2"}, "alternative-id": ["10.1177/172460088900400206"], "URL": "http://dx.doi.org/10.1177/172460088900400206", "relation": {"cites": []}, "ISSN": ["1724-6008", "1724-6008"], "issn-type": [{"value": "1724-6008", "type": "print"}, {"value": "1724-6008", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:44:20Z", "timestamp": 1575247460906}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 2, 15]]}, "DOI": "10.1158/1538-7445.sabcs17-p4-08-07", "type": "proceedings-article", "created": {"date-parts": [[2018, 2, 15]], "date-time": "2018-02-15T17:58:17Z", "timestamp": 1518717497000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract P4-08-07: PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ER\u03b1 serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive, HER2-negative early breast cancer"], "prefix": "10.1158", "author": [{"given": "N", "family": "Ishida", "sequence": "first", "affiliation": []}, {"given": "Y", "family": "Hatanaka", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Baba", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Hagio", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Okada", "sequence": "additional", "affiliation": []}, {"given": "KC", "family": "Hatanaka", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Matsuno", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Yamashita", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2018, 2, 14]]}, "event": {"name": "Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.SABCS17-P4-08-07", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 20]], "date-time": "2019-05-20T12:55:03Z", "timestamp": 1558356903000}, "score": 16.273708, "issued": {"date-parts": [[2018, 2, 14]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.SABCS17-P4-08-07"], "URL": "http://dx.doi.org/10.1158/1538-7445.sabcs17-p4-08-07"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:27:05Z", "timestamp": 1574238425755}, "publisher-location": "Chichester, UK", "reference-count": 38, "publisher": "John Wiley & Sons, Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/14651858.cd006272", "type": "reference-entry", "created": {"date-parts": [[2006, 10, 20]], "date-time": "2006-10-20T04:02:14Z", "timestamp": 1161316934000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Comparison of clinical efficacy of serotonin receptor antagonists in highly emetogenic chemotherapy"], "prefix": "10.1002", "author": [{"given": "Atto", "family": "Billio", "sequence": "first", "affiliation": []}, {"given": "Mike J", "family": "Clarke", "sequence": "additional", "affiliation": []}, {"given": "Enrico", "family": "Morello", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2006, 10, 18]]}, "reference": [{"issue": "18", "key": "10.1002/14651858.CD006272-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "2932", "DOI": "10.1200/JCO.2006.06.9591", "article-title": "American society of clinical oncology guideline for antiemetics in oncology: update 2006", "volume": "24", "author": "Kris", "year": "2006", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272-BIB2|cit2", "volume": "56", "first-page": "729", "year": "1999", "article-title": "ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery", "journal-title": "American Journal of Health-System Pharmacy", "DOI": "10.1093/ajhp/56.8.729", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "10.1002/14651858.CD006272-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.2165/00003495-199754020-00008", "article-title": "Dolasetron: a review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery", "volume": "54", "author": "Balfour", "year": "1997", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1111/j.1365-2125.1993.tb04164.x", "article-title": "The pharmacokinetics of intravenous Ondansetron in patients with hepatic impairment", "volume": "35", "author": "Blake", "year": "1993", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1111/j.1365-2125.1994.tb04397.x", "article-title": "Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of Granisetron", "volume": "38", "author": "Bloomer", "year": "1994", "journal-title": "British Journal of Clinical Pharmacology"}, {"issue": "5", "key": "10.1002/14651858.CD006272-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1097/00130404-200209000-00012", "article-title": "5-HT3-receptor antagonists and the cytochrome p450 system: clinical implications", "volume": "8", "author": "Blower", "year": "2002", "journal-title": "Cancer Journal"}, {"issue": "2", "key": "10.1002/14651858.CD006272-BIB7|cit7", "first-page": "93", "article-title": "Granisetron: relating pharmacology to clinical efficacy", "volume": "11", "author": "Blower", "year": "2003", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.2165/00003495-198300251-00003", "article-title": "Neuropharmacology of chemotherapy induced emesis", "volume": "25", "author": "Borison", "year": "1983", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272-BIB9|cit9", "author": "Clarke", "year": "2006", "article-title": "Cochrane and National Library of Medicine randomized controlled trial and controlled clinical trial criteria", "volume-title": "Cochrane Reviewers` Handbook 4.2.3 (updated November 2004); Appendix 5a"}, {"key": "10.1002/14651858.CD006272-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1097/00000441-198701000-00008", "article-title": "The management of nausea and vomiting in clinical oncology", "volume": "293", "author": "Craig", "year": "1987", "journal-title": "The American Journal of the Medical Sciences"}, {"key": "10.1002/14651858.CD006272-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "1721", "DOI": "10.1200/JCO.1990.8.10.1721", "article-title": "Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens", "volume": "8", "author": "Cubeddu", "year": "1990", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1056/NEJM199003223221204", "article-title": "Efficacy of Ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting", "volume": "322", "author": "Cubeddu", "year": "1990", "journal-title": "New England Journal of Medicine"}, {"key": "10.1002/14651858.CD006272-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1007/s005200000222", "article-title": "The importance of cytochrome P450 monoxygenase CYP2D6 in palliative medicine", "volume": "9", "author": "Davis", "year": "2001", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "2301", "DOI": "10.1002/1097-0142(20001201)89:11<2301::AID-CNCR19>3.0.CO;2-6", "article-title": "Granisetron is equivalent to Ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting", "volume": "89", "author": "Giglio", "year": "2000", "journal-title": "Cancer"}, {"key": "10.1002/14651858.CD006272-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "i77", "DOI": "10.1093/annonc/mdi805", "article-title": "ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)", "volume": "16 Supplement 1", "author": "Herrstedt", "year": "2005", "journal-title": "Annals of Oncology"}, {"key": "10.1002/14651858.CD006272-BIB16|cit16", "first-page": "6", "article-title": "Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis", "volume": "22 (Suppl 10)", "author": "Ettinger", "year": "1995", "journal-title": "Seminars in Oncology"}, {"key": "10.1002/14651858.CD006272-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1002/j.1552-4604.1996.tb04190.x", "article-title": "Pharmacokinetics of Ondansetron in patients with hepatic insufficiency", "volume": "36", "author": "Figg", "year": "1996", "journal-title": "Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/0014-2999(78)90228-5", "article-title": "Blockade of neuronal tryptamine receptors by metoclopramide", "volume": "49", "author": "Fozard", "year": "1978", "journal-title": "European Journal of Pharmacology"}, {"key": "10.1002/14651858.CD006272-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1056/NEJM198110153051601", "article-title": "Antiemetic efficacy of high-dose metoclopramide: randomised trials with placebo and plochlorperazine in patients with chemotherapy-induced nausea and vomiting", "volume": "305", "author": "Gralla", "year": "1981", "journal-title": "New England Journal of Medicine"}, {"key": "10.1002/14651858.CD006272-BIB20|cit20", "first-page": "655", "article-title": "Treating emesis: an overview of agents", "volume": "16", "author": "Gralla", "year": "1991", "journal-title": "P&T"}, {"key": "10.1002/14651858.CD006272-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "1568", "DOI": "10.1200/JCO.1998.16.4.1568", "article-title": "Single dose Granisetron has equivalent anti-emetic efficacy to intravenous Ondansetron for highly emetogenic cisplatin-based chemotherapy", "volume": "16", "author": "Gralla", "year": "1998", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272-BIB22|cit22", "author": "Grunberg", "first-page": "250a (abstr 996", "year": "2003", "article-title": "Incidence and impact of nausea/vomiting with modern antiemetic: Perception vs reality", "series-title": "Proc American Society of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272-BIB23|cit23", "first-page": "191", "article-title": "Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice", "volume": "4", "author": "Hesketh", "year": "1999", "journal-title": "The Oncologist"}, {"key": "10.1002/14651858.CD006272-BIB24|cit24", "unstructured": "Hoechst Marion Russel Inc Anzemet (dolasetron mesylate) tablets and injection. Prescribing information Hoechst Marion Russel 1999"}, {"key": "10.1002/14651858.CD006272-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "2805", "DOI": "10.1200/JCO.2002.09.064", "article-title": "Patient-tailored anti-emetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P450 2D6 genotypes", "volume": "20", "author": "Kaiser", "year": "2002", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1007/s00520-001-0335-y", "article-title": "Antiemetic guidelines: creating a more practical treatment approach", "volume": "10", "author": "Koeller", "year": "2002", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1007/BF00365581", "article-title": "Delayed emesis following anticancer chemotherapy", "volume": "2", "author": "Kris", "year": "1994", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272-BIB28|cit28", "first-page": "456", "article-title": "Meta-analysis of granisetron against ondansetron: efficacy and security in the prevention of acute emesis induced by chemotherapy with high doses of cisplatino", "volume": "115", "author": "Mendarte", "year": "2000", "journal-title": "Medicina Clinica (Barcelona)"}, {"key": "10.1002/14651858.CD006272-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1001/jama.1963.03710020036011", "article-title": "A controlled clinical evaluation of antiemetic drugs", "volume": "186", "author": "Moertel", "year": "1963", "journal-title": "JAMA"}, {"key": "10.1002/14651858.CD006272-BIB30|cit30", "first-page": "22", "article-title": "Efficacy and safety of Granisetron (Kytril) in two special patient populations: children and adults with impaired hepatic function", "volume": "[suppl 5]", "author": "Palmer", "year": "1994", "journal-title": "Seminars in Surgical Oncology 21"}, {"key": "10.1002/14651858.CD006272-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "754", "DOI": "10.1200/JCO.1998.16.2.754", "article-title": "Comparison of single-dose oral Granisetron versus intravenous Ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomised parallel study", "volume": "16", "author": "Perez", "year": "1998", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272-BIB32|cit32", "first-page": "925", "article-title": "Tropisetron A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential as an anti-emetic", "volume": "46", "author": "Rhoda", "year": "1993", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1093/ije/31.1.150", "article-title": "Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed", "volume": "31", "author": "Robinson KA Dickersin", "year": "2002", "journal-title": "International Journal of Epidemiology"}, {"key": "10.1002/14651858.CD006272-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "R1", "DOI": "10.1016/0014-2999(94)90048-5", "article-title": "Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis", "volume": "262", "author": "Rudd", "year": "1994", "journal-title": "European Journal of Pharmacology"}, {"key": "10.1002/14651858.CD006272-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.7326/0003-4819-95-3-352", "article-title": "The control of chemotherapy-induced emesis", "volume": "95", "author": "Siegel", "year": "1981", "journal-title": "Annals of Internal Medicine"}, {"key": "10.1002/14651858.CD006272-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "2683", "DOI": "10.1001/jama.1982.03320440031028", "article-title": "Intravenous metoclopramide: an effective antiemetic in cancer chemotherapy", "volume": "247", "author": "Strum", "year": "1982", "journal-title": "JAMA"}, {"issue": "Supplement 4", "key": "10.1002/14651858.CD006272-BIB37|cit37", "first-page": "iv 20-2", "article-title": "Receptors of the enteric nervous system: potential targets for drug therapy", "volume": "47", "author": "Tack", "year": "2000", "journal-title": "Gut"}, {"issue": "1179", "key": "10.1002/14651858.CD006272-BIB38|cit38", "first-page": "27", "article-title": "Palonosetron (Aloxi) for prevention of nausea and vomiting due to cancer chemotherapy", "volume": "46", "year": "2004", "journal-title": "The Medical Letter"}], "container-title": ["Cochrane Database of Systematic Reviews"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD006272", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 21]], "date-time": "2019-04-21T23:03:15Z", "timestamp": 1555887795000}, "score": 16.109241, "editor": [{"given": "Atto", "family": "Billio", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2006, 10, 18]]}, "references-count": 38, "URL": "http://dx.doi.org/10.1002/14651858.cd006272", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T07:02:22Z", "timestamp": 1574406142316}, "publisher-location": "Chichester, UK", "reference-count": 66, "publisher": "John Wiley & Sons, Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/14651858.cd006272.pub2", "type": "reference-entry", "created": {"date-parts": [[2010, 1, 18]], "date-time": "2010-01-18T18:45:01Z", "timestamp": 1263840301000}, "source": "Crossref", "is-referenced-by-count": 17, "title": ["Serotonin receptor antagonists for highly emetogenic chemotherapy in adults"], "prefix": "10.1002", "author": [{"given": "Atto", "family": "Billio", "sequence": "first", "affiliation": []}, {"given": "Enrico", "family": "Morello", "sequence": "additional", "affiliation": []}, {"given": "Mike J", "family": "Clarke", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 1, 20]]}, "reference": [{"key": "10.1002/14651858.CD006272.pub2-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "1441", "DOI": "10.1093/annonc/mdl137", "article-title": "A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy", "volume": "17", "author": "Aapro", "year": "2006", "journal-title": "Annals of Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB2|cit2", "first-page": "807", "article-title": "A double-blind randomised comparison of the anti-emetic efficacy of two intravenous dose of dolasetron mesylate\u00a0and granisetron in patients receiving high dose cisplatin chemotherapy", "volume": "32A", "author": "Audhuy", "year": "1996", "journal-title": "European Journal of Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1093/oxfordjournals.annonc.a059320", "article-title": "Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis", "volume": "6", "author": "Del", "year": "1995", "journal-title": "Annals of Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1945", "DOI": "10.1002/1097-0142(19941001)74:7<1945::AID-CNCR2820740720>3.0.CO;2-C", "article-title": "Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting", "volume": "74", "author": "Gebbia", "year": "1994", "journal-title": "Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1568", "DOI": "10.1200/JCO.1998.16.4.1568", "article-title": "Single dose oral granisetron has equivalent anti-emetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy", "volume": "16", "author": "Gralla", "year": "1998", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "2242", "DOI": "10.1200/JCO.1996.14.8.2242", "article-title": "Double-blind, randomised comparison of the anti-emetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer", "volume": "14", "author": "Hesketh", "year": "1996", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1177/147323000203000302", "article-title": "Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron", "volume": "30", "author": "Kang", "year": "2002", "journal-title": "Journal of International Medical Research"}, {"key": "10.1002/14651858.CD006272.pub2-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.1002/(SICI)1097-0142(19960301)77:5<941::AID-CNCR21>3.0.CO;2-2", "article-title": "Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial", "volume": "77", "author": "Mantovani", "year": "1996", "journal-title": "Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1016/0959-8049(95)00519-6", "article-title": "An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens", "volume": "324", "author": "Martoni", "year": "1996", "journal-title": "European Journal of Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1097/00001813-199502001-00004", "article-title": "Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis?", "volume": "6 (Suppl 1)", "author": "Marty", "year": "1995", "journal-title": "Anti-Cancer Drugs"}, {"key": "10.1002/14651858.CD006272.pub2-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "1242", "DOI": "10.1200/JCO.1995.13.5.1242", "article-title": "Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis", "volume": "13", "author": "Navari", "year": "1995", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "636", "DOI": "10.1016/S0011-393X(02)80068-6", "article-title": "Clinical assessment of ramosetron HCL oral preparation\u00a0in the treatment of nausea and vomiting induced by cisplatin: a multicenter, randomized, parallel design, double blind comparative study with ondansetron HCL", "volume": "63", "author": "Noda", "year": "2002", "journal-title": "Current Therapeutic Research"}, {"key": "10.1002/14651858.CD006272.pub2-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1097/00000421-199712000-00007", "article-title": "A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy", "volume": "20", "author": "Park", "year": "1997", "journal-title": "American Journal of Clinical Oncology (CCT)"}, {"key": "10.1002/14651858.CD006272.pub2-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1159/000227321", "article-title": "Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomized, parallel-group study", "volume": "51", "author": "Ruff", "year": "1994", "journal-title": "Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/S1470-2045(08)70313-9", "article-title": "Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double blind, double dummy, randomised, comparative phase III trial", "volume": "10", "author": "Saito", "year": "2009", "journal-title": "Lancet Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB16|cit16", "first-page": "432", "article-title": "A comparison of oral ondansetron and intravenous granisetron for the prevention of nausea and emesis associated with cisplatin-based chemotherapy", "volume": "3", "author": "Spector", "year": "1998", "journal-title": "Oncologist"}, {"key": "10.1002/14651858.CD006272.pub2-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1007/s005209900120", "article-title": "Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysis", "volume": "8", "author": "Barrajon", "year": "2000", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB18|cit18", "first-page": "135", "article-title": "Comparison of granisetron vs ondansetron vs tropisetron in the prophylaxis of acute nausea and vomiting induced by high-dose cisplatin for treatment of primary head and neck cancer: an open randomized controlled trial", "volume": "7 (Suppl 5)", "author": "Bianchi", "year": "1996", "journal-title": "Annals of Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1097/00000421-200004000-00016", "article-title": "Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis", "volume": "33", "author": "Chua", "year": "2000", "journal-title": "American Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1007/s005200050027", "article-title": "Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-adryamicin and by high dose ifosfamide delivered in multiple-day continuous infusions", "volume": "8", "author": "Forni", "year": "2000", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1159/000074533", "article-title": "A double-blind, crossover, randomised comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint?", "volume": "49", "author": "Koizumi", "year": "2003", "journal-title": "Chemotherapy"}, {"key": "10.1002/14651858.CD006272.pub2-BIB22|cit22", "author": "Nakamura", "year": "1999", "article-title": "A multicenter randomised parallel comparison of granisetron injection (GRA) with ondansetron injection (OND) in the acute emesis induced by emetogenic chemotherapy", "series-title": "ASCO proceedings, abstract 2324"}, {"key": "10.1002/14651858.CD006272.pub2-BIB23|cit23", "first-page": "287", "article-title": "Antiemetic control in cancer patients treated with highly emetogenic chemotherapy", "volume": "5", "author": "Raynov", "year": "2000", "journal-title": "Journal of B.U.ON: official journal of the Balkan Union of Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB24|cit24", "first-page": "1959", "article-title": "A randomized cross-over comparison of azasetron and granisetron in the prophylaxis of emesis induced by chemotherapy including cisplatin", "volume": "22", "author": "Tsukuda", "year": "1995", "journal-title": "Journal of Cancer and Chemotherapy"}, {"issue": "1", "key": "10.1002/14651858.CD006272.pub2-BIB25|cit25", "first-page": "99", "article-title": "The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial", "volume": "17", "author": "Zhaocai", "year": "2008", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "2932", "DOI": "10.1200/JCO.2006.06.9591", "article-title": "American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006", "volume": "24", "author": "Kris", "year": "2006", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB27|cit27", "volume": "56", "first-page": "729", "year": "1999", "article-title": "ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and paediatric patients receiving chemotherapy or radiation therapy or undergoing surgery", "journal-title": "American Journal of Health-System Pharmacy", "DOI": "10.1093/ajhp/56.8.729", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD006272.pub2-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.2165/00003495-199754020-00008", "article-title": "Dolasetron: a review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery", "volume": "54", "author": "Balfour", "year": "1997", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272.pub2-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1111/j.1365-2125.1993.tb04164.x", "article-title": "The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment", "volume": "35", "author": "Blake", "year": "1994", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1111/j.1365-2125.1994.tb04397.x", "article-title": "Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron", "volume": "38", "author": "Bloomer", "year": "1994", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1097/00130404-200209000-00012", "article-title": "5-HT3-receptor antagonists and the cytochrome p450 system: clinical implications", "volume": "8", "author": "Blower", "year": "2002", "journal-title": "Cancer Journal"}, {"key": "10.1002/14651858.CD006272.pub2-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.2165/00003495-198300251-00003", "article-title": "Neuropharmacology of chemotherapy induced emesis", "volume": "25", "author": "Borison", "year": "1983", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272.pub2-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1097/00000441-198701000-00008", "article-title": "The management of nausea and vomiting in clinical oncology", "volume": "293", "author": "Craig", "year": "1987", "journal-title": "American Journal of the Medical Sciences"}, {"key": "10.1002/14651858.CD006272.pub2-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "1721", "DOI": "10.1200/JCO.1990.8.10.1721", "article-title": "Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens", "volume": "8", "author": "Cubeddu", "year": "1990", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1056/NEJM199003223221204", "article-title": "Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting", "volume": "322", "author": "Cubeddu", "year": "1994", "journal-title": "New England Journal of Medicine"}, {"key": "10.1002/14651858.CD006272.pub2-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1007/s005200000222", "article-title": "The importance of cytochrome P450 monoxygenase CYP2D6 in palliative medicine", "volume": "9", "author": "Davis", "year": "2001", "journal-title": "Support Care Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "2301", "DOI": "10.1002/1097-0142(20001201)89:11<2301::AID-CNCR19>3.0.CO;2-6", "article-title": "Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting", "volume": "89", "author": "Giglio", "year": "2000", "journal-title": "Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "1286", "DOI": "10.1136/bmj.309.6964.1286", "article-title": "Systematic review: identifying relevant studies for systematic review", "volume": "309", "author": "Dickersin", "year": "1994", "journal-title": "BMJ"}, {"issue": "Suppl 10", "key": "10.1002/14651858.CD006272.pub2-BIB39|cit39", "first-page": "6", "article-title": "Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis", "volume": "22", "author": "Ettinger", "year": "1995", "journal-title": "Seminars in Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1002/j.1552-4604.1996.tb04190.x", "article-title": "Pharmacokinetics of ondansetron in patients with hepatic insufficiency", "volume": "36", "author": "Figg", "year": "1996", "journal-title": "Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/0014-2999(78)90228-5", "article-title": "Blockade of neuronal tryptamine receptors by metoclopramide", "volume": "49", "author": "Fozard", "year": "1978", "journal-title": "European Journal of Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1007/978-3-642-84138-5_9", "article-title": "Controlling emesis in patients receiving chemotherapy", "volume": "121", "author": "Gralla", "year": "1991", "journal-title": "Recent Results in Cancer Research"}, {"key": "10.1002/14651858.CD006272.pub2-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "2971", "DOI": "10.1200/JCO.1999.17.9.2971", "article-title": "Recommendations for the use of antiemetics: evidence-based clinical practice guidelines", "volume": "9", "author": "Gralla", "year": "1999", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB44|cit44", "first-page": "250a", "article-title": "Incidence and impact of nausea/vomiting with modern antiemetic: perception vs. reality", "volume": "21", "author": "Grunberg", "year": "2003", "journal-title": "Proceedings American Society of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB45|cit45", "first-page": "191", "article-title": "Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice", "volume": "4", "author": "Hesketh", "year": "1999", "journal-title": "Oncologist"}, {"key": "10.1002/14651858.CD006272.pub2-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "4112", "DOI": "10.1200/JCO.2003.01.095", "article-title": "The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - the aprepitant Protocol 052 Study Group", "volume": "21", "author": "Hesketh", "year": "2003", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB47|cit47", "unstructured": "Higgins J Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org", "DOI": "10.1002/9780470712184", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD006272.pub2-BIB48|cit48", "unstructured": "Hoechst Marion Russel Inc Anzemet (dolasetron mesylate) tablets and injection. Prescribing information Hoechst Marion Russel 1999"}, {"key": "10.1002/14651858.CD006272.pub2-BIB49|cit49", "unstructured": "Jadad AR Moore RA Carroll D Jenkinson C Reynolds DJ Gavaghan DJ Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 1 12", "DOI": "10.1016/0197-2456(95)00134-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD006272.pub2-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1007/s00520-006-0186-7", "article-title": "A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis", "volume": "15", "author": "Jordan", "year": "2007", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "2805", "DOI": "10.1200/JCO.2002.09.064", "article-title": "Patient-tailored anti-emetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P450 2D6 genotypes", "volume": "20", "author": "Kaiser", "year": "2002", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1007/s00520-001-0335-y", "article-title": "Antiemetic guidelines: creating a more practical treatment approach", "volume": "10", "author": "Koeller", "year": "2002", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1007/BF00365581", "article-title": "Delayed emesis following anticancer chemotherapy", "volume": "2", "author": "Kris", "year": "1994", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB54|cit54", "author": "Gralla", "year": "2008", "article-title": "Consensus conference on antiemetic therapy: update", "series-title": "Multinational Association of Supportive Cancer"}, {"key": "10.1002/14651858.CD006272.pub2-BIB55|cit55", "first-page": "456", "article-title": "Meta-analysis of granisetron versus ondansetron: efficacy and safety in the prevention of acute emesis induced by high dose cisplatin containing schedules", "volume": "115", "author": "Mendarte", "year": "2000", "journal-title": "Medicina Cl\u00ednica (Barcelona)"}, {"key": "10.1002/14651858.CD006272.pub2-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1001/jama.1963.03710020036011", "article-title": "A controlled clinical evaluation of antiemetic drugs", "volume": "186", "author": "Moertel", "year": "1963", "journal-title": "JAMA"}, {"key": "10.1002/14651858.CD006272.pub2-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1081/CNV-200027137", "article-title": "Role of neurokinin-1-receptor antagonists in chemotherapy-induced emesis: summary of clinical trials", "volume": "22", "author": "Navari", "year": "2004", "journal-title": "Cancer Investigations"}, {"key": "10.1002/14651858.CD006272.pub2-BIB58|cit58", "first-page": "22", "article-title": "Efficacy and safety of granisetron (Kytril) in two special patient population: children and adults with impaired hepatic function", "volume": "21", "author": "Palmer", "year": "1994", "journal-title": "Seminars in Surgical Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB59|cit59", "unstructured": "The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2008"}, {"key": "10.1002/14651858.CD006272.pub2-BIB60|cit60", "first-page": "925", "article-title": "Tropisetron A review of its pharmacodynamic properties and therapeutic potential as an anti-emetic", "volume": "46", "author": "Rhoda", "year": "1993", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272.pub2-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "R1", "DOI": "10.1016/0014-2999(94)90048-5", "article-title": "Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis", "volume": "262", "author": "Rudd", "year": "1994", "journal-title": "European Journal of Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB62|cit62", "first-page": "946", "article-title": "Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?", "volume": "21", "author": "Schwartzberg", "year": "2007", "journal-title": "Oncology"}, {"key": "10.1002/14651858.CD006272.pub2-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.7326/0003-4819-95-3-352", "article-title": "The control of chemotherapy-induced emesis", "volume": "95", "author": "Siegel", "year": "1981", "journal-title": "Annals of Internal Medicine"}, {"key": "10.1002/14651858.CD006272.pub2-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "2683", "DOI": "10.1001/jama.1982.03320440031028", "article-title": "Intravenous metoclopramide: an effective antiemetic in cancer chemotherapy", "volume": "247", "author": "Strum", "year": "1982", "journal-title": "JAMA"}, {"issue": "4", "key": "10.1002/14651858.CD006272.pub2-BIB65|cit65", "first-page": "iv; 20-2", "article-title": "Receptors of the enteric nervous system: potential targets for drug therapy", "volume": "47", "author": "Tack", "year": "2000", "journal-title": "Gut"}, {"issue": "179", "key": "10.1002/14651858.CD006272.pub2-BIB66|cit66", "first-page": "27", "article-title": "Palonosetron (Aloxi) for prevention of nausea and vomiting due to cancer chemotherapy", "volume": "46", "year": "2004", "journal-title": "The Medical Letter"}], "container-title": ["Cochrane Database of Systematic Reviews"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD006272.pub2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 25]], "date-time": "2019-05-25T06:25:03Z", "timestamp": 1558765503000}, "score": 16.109241, "editor": [{"given": "Atto", "family": "Billio", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2010, 1, 20]]}, "references-count": 66, "URL": "http://dx.doi.org/10.1002/14651858.cd006272.pub2", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:08Z", "timestamp": 1574488988389}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1992, 10, 1]], "date-time": "1992-10-01T00:00:00Z", "timestamp": 717897600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1992, 10]]}, "DOI": "10.1038/bjc.1992.343", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:05:07Z", "timestamp": 1295003107000}, "page": "712-716", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer"], "prefix": "10.1038", "volume": "66", "author": [{"given": "L", "family": "Kaklamanis", "sequence": "first", "affiliation": []}, {"given": "KC", "family": "Gatter", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Mortensen", "sequence": "additional", "affiliation": []}, {"given": "AL", "family": "Harris", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1992343.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1992343", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1992343.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T06:17:34Z", "timestamp": 1552889854000}, "score": 15.752554, "issued": {"date-parts": [[1992, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 10]]}, "issue": "4"}, "alternative-id": ["BFbjc1992343"], "URL": "http://dx.doi.org/10.1038/bjc.1992.343", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T00:07:56Z", "timestamp": 1574208476300}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1998, 8, 1]], "date-time": "1998-08-01T00:00:00Z", "timestamp": 901929600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Growth Hormone & IGF Research"], "published-print": {"date-parts": [[1998, 8]]}, "DOI": "10.1016/s1096-6374(98)80148-2", "type": "journal-article", "created": {"date-parts": [[2006, 5, 26]], "date-time": "2006-05-26T11:27:42Z", "timestamp": 1148642862000}, "page": "316", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Progesterone modulates the effects of estrogen on IGFI in post-menopausal women"], "prefix": "10.1016", "volume": "8", "author": [{"given": "KKY", "family": "Ho", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Crampton", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Nguyen", "sequence": "additional", "affiliation": []}, {"given": "AT", "family": "Reutens", "sequence": "additional", "affiliation": []}, {"given": "KC", "family": "Leung", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Growth Hormone & IGF Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1096637498801482?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1096637498801482?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 16]], "date-time": "2019-01-16T08:26:30Z", "timestamp": 1547627190000}, "score": 15.648009, "issued": {"date-parts": [[1998, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 8]]}, "issue": "4"}, "alternative-id": ["S1096637498801482"], "URL": "http://dx.doi.org/10.1016/s1096-6374(98)80148-2", "ISSN": ["1096-6374"], "issn-type": [{"value": "1096-6374", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T22:46:56Z", "timestamp": 1575067616613}, "reference-count": 24, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3864, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Vet Pharmacol Ther"], "published-print": {"date-parts": [[2005, 2]]}, "DOI": "10.1111/j.1365-2885.2004.00623.x", "type": "journal-article", "created": {"date-parts": [[2005, 2, 18]], "date-time": "2005-02-18T08:50:12Z", "timestamp": 1108716612000}, "page": "37-44", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Pharmacokinetics of ibafloxacin in healthy cats."], "prefix": "10.1111", "volume": "28", "author": [{"given": "M.", "family": "COULET", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "MORELLO", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "COX", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "LOHUIS", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "b1_86", "author": "Birkett D.J.", "volume": "17", "first-page": "36", "year": "1994", "journal-title": "Australian Prescriber", "DOI": "10.18773/austprescr.1994.046", "doi-asserted-by": "crossref"}, {"key": "b2_87", "author": "Boothe D.D.", "volume": "3", "first-page": "409", "year": "2002", "journal-title": "Veterinary Therapeutics"}, {"key": "b3_88", "DOI": "10.1007/s002280050202", "doi-asserted-by": "publisher"}, {"key": "b4_89", "author": "Brown S.A.", "volume": "19", "first-page": "1", "year": "1996", "journal-title": "Journal of Veterinary Pharmacology and Therapeutics", "DOI": "10.1111/j.1365-2885.1996.tb00001.x", "doi-asserted-by": "crossref"}, {"key": "b5_90", "author": "Caldwell J.", "first-page": "85", "year": "1980", "volume-title": "Enzymatic Basic of Detoxication", "DOI": "10.1016/B978-0-12-380001-5.50011-6", "doi-asserted-by": "crossref"}, {"key": "b6_91", "author": "Cester C.C.", "volume": "147", "first-page": "703", "year": "1996", "journal-title": "Revue de Medecine Veterinaire"}, {"key": "b7_92", "DOI": "10.1046/j.1365-2885.2002.00438.x", "doi-asserted-by": "publisher"}, {"key": "b8_93", "DOI": "10.1046/j.1365-2885.2002.00361.x", "doi-asserted-by": "publisher"}, {"key": "b9_94", "author": "Coulet M.V.", "volume": "28", "first-page": "29", "year": "2004", "journal-title": "Journal of Veterinary Pharmacology and Therapeutics", "DOI": "10.1111/j.1365-2885.2004.00622.x", "doi-asserted-by": "crossref"}, {"key": "b10_95", "DOI": "10.1097/00008571-200006000-00009", "doi-asserted-by": "publisher"}, {"key": "b11_96", "author": "Ehrlich A.", "volume": "21", "first-page": "47", "year": "1999", "journal-title": "Methods and Findings in Experimental and Clinical Pharmacology", "DOI": "10.1358/mf.1999.21.1.527018", "doi-asserted-by": "crossref"}, {"key": "b12_97", "author": "Greene C.E.", "first-page": "473", "year": "1993", "volume-title": "Quinolone Antimicrobial Agents"}, {"key": "b13_98", "DOI": "10.1046/j.1365-2885.2002.00381.x", "doi-asserted-by": "publisher"}, {"key": "b14_99", "DOI": "10.1111/j.1365-2885.2004.00561.x", "doi-asserted-by": "publisher"}, {"key": "b15_100", "DOI": "10.1046/j.1365-3164.1999.00179.x", "doi-asserted-by": "publisher"}, {"key": "b16_101", "author": "Kung K.", "volume": "16", "first-page": "462", "year": "1993", "journal-title": "Journal of Veterinary Pharmacology and Therapeutics", "DOI": "10.1111/j.1365-2885.1993.tb00212.x", "doi-asserted-by": "crossref"}, {"key": "b17_102", "DOI": "10.1046/j.1365-2885.1997.00045.x", "doi-asserted-by": "publisher"}, {"key": "b18_103", "author": "Ledergerber B.", "volume": "27", "first-page": "350", "year": "1985", "journal-title": "Antimicrobial Agents and Chemotherapy", "DOI": "10.1128/AAC.27.3.350", "doi-asserted-by": "crossref"}, {"key": "b19_104", "DOI": "10.1016/S1090-0233(02)00168-5", "doi-asserted-by": "publisher"}, {"key": "b20_105", "author": "Melander ?.", "volume": "43", "first-page": "34", "year": "1984", "journal-title": "World Review of Nutrition and Dietetics", "DOI": "10.1159/000409057", "doi-asserted-by": "crossref"}, {"key": "b21_106", "DOI": "10.1046/j.1365-2885.1997.00095.x", "doi-asserted-by": "publisher"}, {"key": "b22_107", "author": "Vree T.B.", "volume": "17", "first-page": "80", "year": "1994", "journal-title": "Journal of Veterinary Pharmacology and Therapeutics", "DOI": "10.1111/j.1365-2885.1994.tb00527.x", "doi-asserted-by": "crossref"}, {"key": "b23_108", "author": "Walker R.D.", "volume": "78", "first-page": "84", "year": "2000", "journal-title": "Australian Veterinary Journal", "DOI": "10.1111/j.1751-0813.2000.tb10528.x", "doi-asserted-by": "crossref"}, {"key": "b24_109", "author": "Wilcke J.R.", "volume": "20", "first-page": "177", "year": "1988", "journal-title": "Le point Veterinaire"}], "container-title": ["Journal of Veterinary Pharmacology and Therapeutics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2885.2004.00623.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 28]], "date-time": "2019-01-28T00:45:31Z", "timestamp": 1548636331000}, "score": 15.584238, "issued": {"date-parts": [[2005, 2]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2005, 2]]}, "issue": "1"}, "alternative-id": ["10.1111/j.1365-2885.2004.00623.x"], "URL": "http://dx.doi.org/10.1111/j.1365-2885.2004.00623.x", "relation": {"cites": []}, "ISSN": ["0140-7783", "1365-2885"], "issn-type": [{"value": "0140-7783", "type": "print"}, {"value": "1365-2885", "type": "electronic"}], "subject": ["Pharmacology", "General Veterinary"]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T21:58:26Z", "timestamp": 1575410306978}, "update-to": [{"updated": {"date-parts": [[2013, 12, 9]], "date-time": "2013-12-09T00:00:00Z", "timestamp": 1386547200000}, "DOI": "10.1002/14651858.cd006272.pub2", "type": "withdrawal", "label": "Withdrawal"}], "reference-count": 66, "publisher": "Wiley", "content-domain": {"domain": ["wiley.com", "cochranelibrary.com"], "crossmark-restriction": true}, "DOI": "10.1002/14651858.cd006272.pub3", "type": "journal-article", "created": {"date-parts": [[2013, 12, 9]], "date-time": "2013-12-09T16:38:50Z", "timestamp": 1386607130000}, "update-policy": "http://dx.doi.org/10.1002/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Serotonin receptor antagonists for highly emetogenic chemotherapy in adults"], "prefix": "10.1002", "author": [{"given": "Atto", "family": "Billio", "sequence": "first", "affiliation": [{"name": "Central Hospital S, Maurizio; Department of Haematology and Bone Marrow Transplantation; Bolzano Italy 39100"}]}, {"given": "Enrico", "family": "Morello", "sequence": "additional", "affiliation": [{"name": "Spedali Civili di Brescia; Haematology Department; Brescia Italy 25100"}]}, {"given": "Mike J", "family": "Clarke", "sequence": "additional", "affiliation": [{"name": "Queen's University Belfast; Centre for Public Health; Institute of Clinical Sciences, Block B, Royal Victoria Hospital Grosvenor Road Belfast Northern Ireland UK BT12 6BJ"}]}], "member": "311", "published-online": {"date-parts": [[2013, 12, 9]]}, "reference": [{"key": "10.1002/14651858.CD006272.pub3-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "1441", "DOI": "10.1093/annonc/mdl137", "article-title": "A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy", "volume": "17", "author": "Aapro", "year": "2006", "journal-title": "Annals of Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB2|cit2", "first-page": "807", "article-title": "A double-blind randomised comparison of the anti-emetic efficacy of two intravenous dose of dolasetron mesylate\u00a0and granisetron in patients receiving high dose cisplatin chemotherapy", "volume": "32A", "author": "Audhuy", "year": "1996", "journal-title": "European Journal of Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1093/oxfordjournals.annonc.a059320", "article-title": "Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis", "volume": "6", "author": "Del", "year": "1995", "journal-title": "Annals of Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1945", "DOI": "10.1002/1097-0142(19941001)74:7<1945::AID-CNCR2820740720>3.0.CO;2-C", "article-title": "Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting", "volume": "74", "author": "Gebbia", "year": "1994", "journal-title": "Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1568", "DOI": "10.1200/JCO.1998.16.4.1568", "article-title": "Single dose oral granisetron has equivalent anti-emetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy", "volume": "16", "author": "Gralla", "year": "1998", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "2242", "DOI": "10.1200/JCO.1996.14.8.2242", "article-title": "Double-blind, randomised comparison of the anti-emetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer", "volume": "14", "author": "Hesketh", "year": "1996", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1177/147323000203000302", "article-title": "Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron", "volume": "30", "author": "Kang", "year": "2002", "journal-title": "Journal of International Medical Research"}, {"key": "10.1002/14651858.CD006272.pub3-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.1002/(SICI)1097-0142(19960301)77:5<941::AID-CNCR21>3.0.CO;2-2", "article-title": "Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial", "volume": "77", "author": "Mantovani", "year": "1996", "journal-title": "Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1016/0959-8049(95)00519-6", "article-title": "An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens", "volume": "324", "author": "Martoni", "year": "1996", "journal-title": "European Journal of Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1097/00001813-199502001-00004", "article-title": "Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis?", "volume": "6 (Suppl 1)", "author": "Marty", "year": "1995", "journal-title": "Anti-Cancer Drugs"}, {"key": "10.1002/14651858.CD006272.pub3-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "1242", "DOI": "10.1200/JCO.1995.13.5.1242", "article-title": "Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis", "volume": "13", "author": "Navari", "year": "1995", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "636", "DOI": "10.1016/S0011-393X(02)80068-6", "article-title": "Clinical assessment of ramosetron HCL oral preparation\u00a0in the treatment of nausea and vomiting induced by cisplatin: a multicenter, randomized, parallel design, double blind comparative study with ondansetron HCL", "volume": "63", "author": "Noda", "year": "2002", "journal-title": "Current Therapeutic Research"}, {"key": "10.1002/14651858.CD006272.pub3-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1097/00000421-199712000-00007", "article-title": "A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy", "volume": "20", "author": "Park", "year": "1997", "journal-title": "American Journal of Clinical Oncology (CCT)"}, {"key": "10.1002/14651858.CD006272.pub3-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1159/000227321", "article-title": "Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomized, parallel-group study", "volume": "51", "author": "Ruff", "year": "1994", "journal-title": "Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/S1470-2045(08)70313-9", "article-title": "Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double blind, double dummy, randomised, comparative phase III trial", "volume": "10", "author": "Saito", "year": "2009", "journal-title": "Lancet Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB16|cit16", "first-page": "432", "article-title": "A comparison of oral ondansetron and intravenous granisetron for the prevention of nausea and emesis associated with cisplatin-based chemotherapy", "volume": "3", "author": "Spector", "year": "1998", "journal-title": "Oncologist"}, {"key": "10.1002/14651858.CD006272.pub3-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1007/s005209900120", "article-title": "Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysis", "volume": "8", "author": "Barrajon", "year": "2000", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB18|cit18", "first-page": "135", "article-title": "Comparison of granisetron vs ondansetron vs tropisetron in the prophylaxis of acute nausea and vomiting induced by high-dose cisplatin for treatment of primary head and neck cancer: an open randomized controlled trial", "volume": "7 (Suppl 5)", "author": "Bianchi", "year": "1996", "journal-title": "Annals of Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1097/00000421-200004000-00016", "article-title": "Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis", "volume": "33", "author": "Chua", "year": "2000", "journal-title": "American Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1007/s005200050027", "article-title": "Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-adryamicin and by high dose ifosfamide delivered in multiple-day continuous infusions", "volume": "8", "author": "Forni", "year": "2000", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1159/000074533", "article-title": "A double-blind, crossover, randomised comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint?", "volume": "49", "author": "Koizumi", "year": "2003", "journal-title": "Chemotherapy"}, {"key": "10.1002/14651858.CD006272.pub3-BIB22|cit22", "author": "Nakamura", "year": "1999", "article-title": "A multicenter randomised parallel comparison of granisetron injection (GRA) with ondansetron injection (OND) in the acute emesis induced by emetogenic chemotherapy", "series-title": "ASCO proceedings, abstract 2324"}, {"key": "10.1002/14651858.CD006272.pub3-BIB23|cit23", "first-page": "287", "article-title": "Antiemetic control in cancer patients treated with highly emetogenic chemotherapy", "volume": "5", "author": "Raynov", "year": "2000", "journal-title": "Journal of B.U.ON: official journal of the Balkan Union of Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB24|cit24", "first-page": "1959", "article-title": "A randomized cross-over comparison of azasetron and granisetron in the prophylaxis of emesis induced by chemotherapy including cisplatin", "volume": "22", "author": "Tsukuda", "year": "1995", "journal-title": "Journal of Cancer and Chemotherapy"}, {"issue": "1", "key": "10.1002/14651858.CD006272.pub3-BIB25|cit25", "first-page": "99", "article-title": "The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial", "volume": "17", "author": "Zhaocai", "year": "2008", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "2932", "DOI": "10.1200/JCO.2006.06.9591", "article-title": "American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006", "volume": "24", "author": "Kris", "year": "2006", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB27|cit27", "volume": "56", "first-page": "729", "year": "1999", "article-title": "ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and paediatric patients receiving chemotherapy or radiation therapy or undergoing surgery", "journal-title": "American Journal of Health-System Pharmacy", "DOI": "10.1093/ajhp/56.8.729", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD006272.pub3-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.2165/00003495-199754020-00008", "article-title": "Dolasetron: a review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery", "volume": "54", "author": "Balfour", "year": "1997", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272.pub3-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1111/j.1365-2125.1993.tb04164.x", "article-title": "The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment", "volume": "35", "author": "Blake", "year": "1994", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1111/j.1365-2125.1994.tb04397.x", "article-title": "Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron", "volume": "38", "author": "Bloomer", "year": "1994", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1097/00130404-200209000-00012", "article-title": "5-HT3-receptor antagonists and the cytochrome p450 system: clinical implications", "volume": "8", "author": "Blower", "year": "2002", "journal-title": "Cancer Journal"}, {"key": "10.1002/14651858.CD006272.pub3-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.2165/00003495-198300251-00003", "article-title": "Neuropharmacology of chemotherapy induced emesis", "volume": "25", "author": "Borison", "year": "1983", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272.pub3-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1097/00000441-198701000-00008", "article-title": "The management of nausea and vomiting in clinical oncology", "volume": "293", "author": "Craig", "year": "1987", "journal-title": "American Journal of the Medical Sciences"}, {"key": "10.1002/14651858.CD006272.pub3-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "1721", "DOI": "10.1200/JCO.1990.8.10.1721", "article-title": "Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens", "volume": "8", "author": "Cubeddu", "year": "1990", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1056/NEJM199003223221204", "article-title": "Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting", "volume": "322", "author": "Cubeddu", "year": "1994", "journal-title": "New England Journal of Medicine"}, {"key": "10.1002/14651858.CD006272.pub3-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1007/s005200000222", "article-title": "The importance of cytochrome P450 monoxygenase CYP2D6 in palliative medicine", "volume": "9", "author": "Davis", "year": "2001", "journal-title": "Support Care Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "2301", "DOI": "10.1002/1097-0142(20001201)89:11<2301::AID-CNCR19>3.0.CO;2-6", "article-title": "Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting", "volume": "89", "author": "Giglio", "year": "2000", "journal-title": "Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "1286", "DOI": "10.1136/bmj.309.6964.1286", "article-title": "Systematic review: identifying relevant studies for systematic review", "volume": "309", "author": "Dickersin", "year": "1994", "journal-title": "BMJ"}, {"issue": "Suppl 10", "key": "10.1002/14651858.CD006272.pub3-BIB39|cit39", "first-page": "6", "article-title": "Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis", "volume": "22", "author": "Ettinger", "year": "1995", "journal-title": "Seminars in Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1002/j.1552-4604.1996.tb04190.x", "article-title": "Pharmacokinetics of ondansetron in patients with hepatic insufficiency", "volume": "36", "author": "Figg", "year": "1996", "journal-title": "Journal of Clinical Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/0014-2999(78)90228-5", "article-title": "Blockade of neuronal tryptamine receptors by metoclopramide", "volume": "49", "author": "Fozard", "year": "1978", "journal-title": "European Journal of Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1007/978-3-642-84138-5_9", "article-title": "Controlling emesis in patients receiving chemotherapy", "volume": "121", "author": "Gralla", "year": "1991", "journal-title": "Recent Results in Cancer Research"}, {"key": "10.1002/14651858.CD006272.pub3-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "2971", "DOI": "10.1200/JCO.1999.17.9.2971", "article-title": "Recommendations for the use of antiemetics: evidence-based clinical practice guidelines", "volume": "9", "author": "Gralla", "year": "1999", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB44|cit44", "first-page": "250a", "article-title": "Incidence and impact of nausea/vomiting with modern antiemetic: perception vs. reality", "volume": "21", "author": "Grunberg", "year": "2003", "journal-title": "Proceedings American Society of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB45|cit45", "first-page": "191", "article-title": "Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice", "volume": "4", "author": "Hesketh", "year": "1999", "journal-title": "Oncologist"}, {"key": "10.1002/14651858.CD006272.pub3-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "4112", "DOI": "10.1200/JCO.2003.01.095", "article-title": "The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - the aprepitant Protocol 052 Study Group", "volume": "21", "author": "Hesketh", "year": "2003", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB47|cit47", "unstructured": "Higgins J Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org", "DOI": "10.1002/9780470712184", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD006272.pub3-BIB48|cit48", "unstructured": "Hoechst Marion Russel Inc Anzemet (dolasetron mesylate) tablets and injection. Prescribing information Hoechst Marion Russel 1999"}, {"key": "10.1002/14651858.CD006272.pub3-BIB49|cit49", "unstructured": "Jadad AR Moore RA Carroll D Jenkinson C Reynolds DJ Gavaghan DJ Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 1 12", "DOI": "10.1016/0197-2456(95)00134-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/14651858.CD006272.pub3-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1007/s00520-006-0186-7", "article-title": "A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis", "volume": "15", "author": "Jordan", "year": "2007", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "2805", "DOI": "10.1200/JCO.2002.09.064", "article-title": "Patient-tailored anti-emetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P450 2D6 genotypes", "volume": "20", "author": "Kaiser", "year": "2002", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1007/s00520-001-0335-y", "article-title": "Antiemetic guidelines: creating a more practical treatment approach", "volume": "10", "author": "Koeller", "year": "2002", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1007/BF00365581", "article-title": "Delayed emesis following anticancer chemotherapy", "volume": "2", "author": "Kris", "year": "1994", "journal-title": "Supportive Care in Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB54|cit54", "author": "Gralla", "year": "2008", "article-title": "Consensus conference on antiemetic therapy: update", "series-title": "Multinational Association of Supportive Cancer"}, {"key": "10.1002/14651858.CD006272.pub3-BIB55|cit55", "first-page": "456", "article-title": "Meta-analysis of granisetron versus ondansetron: efficacy and safety in the prevention of acute emesis induced by high dose cisplatin containing schedules", "volume": "115", "author": "Mendarte", "year": "2000", "journal-title": "Medicina Cl\u00ednica (Barcelona)"}, {"key": "10.1002/14651858.CD006272.pub3-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1001/jama.1963.03710020036011", "article-title": "A controlled clinical evaluation of antiemetic drugs", "volume": "186", "author": "Moertel", "year": "1963", "journal-title": "JAMA"}, {"key": "10.1002/14651858.CD006272.pub3-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1081/CNV-200027137", "article-title": "Role of neurokinin-1-receptor antagonists in chemotherapy-induced emesis: summary of clinical trials", "volume": "22", "author": "Navari", "year": "2004", "journal-title": "Cancer Investigations"}, {"key": "10.1002/14651858.CD006272.pub3-BIB58|cit58", "first-page": "22", "article-title": "Efficacy and safety of granisetron (Kytril) in two special patient population: children and adults with impaired hepatic function", "volume": "21", "author": "Palmer", "year": "1994", "journal-title": "Seminars in Surgical Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB59|cit59", "unstructured": "The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2008"}, {"key": "10.1002/14651858.CD006272.pub3-BIB60|cit60", "first-page": "925", "article-title": "Tropisetron A review of its pharmacodynamic properties and therapeutic potential as an anti-emetic", "volume": "46", "author": "Rhoda", "year": "1993", "journal-title": "Drugs"}, {"key": "10.1002/14651858.CD006272.pub3-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "R1", "DOI": "10.1016/0014-2999(94)90048-5", "article-title": "Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis", "volume": "262", "author": "Rudd", "year": "1994", "journal-title": "European Journal of Pharmacology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB62|cit62", "first-page": "946", "article-title": "Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?", "volume": "21", "author": "Schwartzberg", "year": "2007", "journal-title": "Oncology"}, {"key": "10.1002/14651858.CD006272.pub3-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.7326/0003-4819-95-3-352", "article-title": "The control of chemotherapy-induced emesis", "volume": "95", "author": "Siegel", "year": "1981", "journal-title": "Annals of Internal Medicine"}, {"key": "10.1002/14651858.CD006272.pub3-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "2683", "DOI": "10.1001/jama.1982.03320440031028", "article-title": "Intravenous metoclopramide: an effective antiemetic in cancer chemotherapy", "volume": "247", "author": "Strum", "year": "1982", "journal-title": "JAMA"}, {"issue": "4", "key": "10.1002/14651858.CD006272.pub3-BIB65|cit65", "first-page": "iv; 20-2", "article-title": "Receptors of the enteric nervous system: potential targets for drug therapy", "volume": "47", "author": "Tack", "year": "2000", "journal-title": "Gut"}, {"issue": "179", "key": "10.1002/14651858.CD006272.pub3-BIB66|cit66", "first-page": "27", "article-title": "Palonosetron (Aloxi) for prevention of nausea and vomiting due to cancer chemotherapy", "volume": "46", "year": "2004", "journal-title": "The Medical Letter"}], "container-title": ["Cochrane Database of Systematic Reviews"], "language": "en", "deposited": {"date-parts": [[2019, 8, 4]], "date-time": "2019-08-04T18:22:39Z", "timestamp": 1564942959000}, "score": 15.28149, "editor": [{"name": "Cochrane Pain, Palliative and Supportive Care Group", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2013, 12, 9]]}, "references-count": 66, "URL": "http://dx.doi.org/10.1002/14651858.cd006272.pub3", "relation": {"cites": []}, "ISSN": ["1465-1858"], "issn-type": [{"value": "1465-1858", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:10:57Z", "timestamp": 1574115057129}, "reference-count": 0, "publisher": "Bioscientifica", "content-domain": {"domain": ["rep.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2002, 12, 1]]}, "abstract": "<jats:p>In the ovary, cortisol-cortisone interconversion is catalysed by isoforms of 11beta-hydroxysteroid dehydrogenase (11betaHSD). The objective of this study was to establish whether human follicular fluid (hFF), obtained after controlled ovarian hyperstimulation, contains paracrine modulators of 11betaHSD activity. Of 274 hFF samples tested for effects in rat kidney homogenates, 206 hFF samples significantly inhibited NADP(+)-dependent oxidation of cortisol within 1 h (by 11-67% of control 11betaHSD activity), whereas 42 hFF samples significantly stimulated 11betaHSD activity (16-210% increase relative to control). Although charcoal-stripping of hFF prevented the inhibition and potentiated the stimulation of NADP(+)-dependent cortisol oxidation in a renal homogenate, effects of individual hFF samples on NADP(+)-dependent cortisol oxidation were independent of intrafollicular progesterone concentrations. Hydrophilic fractions of hFF samples, isolated by C18 column chromatography, stimulated both the NADP(+)-dependent oxidation of cortisol (by 55+/-5%, n=98) and the NADPH-dependent reduction of cortisone (by 86+/-22%, n= 5). In contrast, the hydrophobic fractions of hFF (eluted at 65-85% methanol) inhibited both NADP(+)-dependent 11beta-dehydrogenase and NADPH-dependent 11-ketosteroid reductase activities (by 63+/-2% and 74+/-4%, respectively). None of the C18 column fractions of 50 hFF samples had any significant effect on NAD(+)-dependent 11beta-dehydrogenase activities. The hydrophobic inhibitors of NADP(H)-dependent cortisol-cortisone metabolism did not co-elute with several candidate compounds (prostaglandins E(2) and F(2alpha), cortisol, cortisone, oestradiol, testosterone, progesterone, pregnenolone or cholesterol). Hence, hFF aspirated from women undergoing controlled ovarian hyperstimulation for assisted conception contains both hydrophilic stimuli and hydrophobic inhibitors of glucocorticoid metabolism which appear to be selective for the NADP(H)-dependent, type 1 isoform of 11betaHSD.</jats:p>", "DOI": "10.1530/rep.0.1240801", "type": "journal-article", "created": {"date-parts": [[2004, 3, 18]], "date-time": "2004-03-18T23:09:32Z", "timestamp": 1079651372000}, "page": "801-812", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Ovarian modulators of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity in follicular fluid from gonadotrophin-stimulated assisted conception cycles"], "prefix": "10.1530", "author": [{"given": "LM", "family": "Thurston", "sequence": "first", "affiliation": []}, {"given": "DP", "family": "Norgate", "sequence": "additional", "affiliation": []}, {"given": "KC", "family": "Jonas", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Chandras", "sequence": "additional", "affiliation": []}, {"given": "HJ", "family": "Kloosterboer", "sequence": "additional", "affiliation": []}, {"given": "BA", "family": "Cooke", "sequence": "additional", "affiliation": []}, {"given": "AE", "family": "Michael", "sequence": "additional", "affiliation": []}], "member": "416", "container-title": ["Reproduction"], "link": [{"URL": "https://rep.bioscientifica.com/view/journals/rep/124/6/801.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T16:42:33Z", "timestamp": 1550248953000}, "score": 14.730171, "issued": {"date-parts": [[2002, 12, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1530/rep.0.1240801", "ISSN": ["1470-1626", "1741-7899"], "issn-type": [{"value": "1470-1626", "type": "print"}, {"value": "1741-7899", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}